BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
Number Citing Articles
1 Othman A, Sekheri M, Filep JG. Roles of neutrophil granule proteins in orchestrating inflammation and immunity. FEBS J 2021. [PMID: 33683814 DOI: 10.1111/febs.15803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kaye R, Botten N, Lippestad M, Li D, Hodges RR, Utheim TP, Serhan CN, Dartt DA. Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells. Exp Eye Res 2019;180:53-62. [PMID: 30513286 DOI: 10.1016/j.exer.2018.11.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yin P, Wei Y, Wang X, Zhu M, Feng J. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. Front Neurol 2018;9:617. [PMID: 30131754 DOI: 10.3389/fneur.2018.00617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
4 Derada Troletti C, Enzmann G, Chiurchiù V, Kamermans A, Tietz SM, Norris PC, Jahromi NH, Leuti A, van der Pol SMA, Schouten M, Serhan CN, de Vries HE, Engelhardt B, Kooij G. Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome. Cell Rep 2021;35:109201. [PMID: 34077725 DOI: 10.1016/j.celrep.2021.109201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chiang N, Libreros S, Norris PC, de la Rosa X, Serhan CN. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions. J Clin Invest 2019;129:5294-311. [PMID: 31657786 DOI: 10.1172/JCI129448] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 27.5] [Reference Citation Analysis]
6 Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities. Front Immunol 2021;12:702785. [PMID: 34276698 DOI: 10.3389/fimmu.2021.702785] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Sekikawa A, Cui C, Sugiyama D, Fabio A, Harris WS, Zhang X. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019;11:E2599. [PMID: 31671524 DOI: 10.3390/nu11112599] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
8 Cardia L, Calapai F, Mondello C, Quattrone D, Elisa Sorbara E, Mannucci C, Calapai G, Mondello E. Clinical use of omega-3 fatty acids in migraine: A narrative review. Medicine (Baltimore) 2020;99:e22253. [PMID: 33080672 DOI: 10.1097/MD.0000000000022253] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sugimoto MA, Vago JP, Perretti M, Teixeira MM. Mediators of the Resolution of the Inflammatory Response. Trends in Immunology 2019;40:212-27. [DOI: 10.1016/j.it.2019.01.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 19.7] [Reference Citation Analysis]
10 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Reference Citation Analysis]
11 Jouvene CC, Shay AE, Soens MA, Norris PC, Haeggström JZ, Serhan CN. Biosynthetic metabolomes of cysteinyl-containing immunoresolvents. FASEB J 2019;33:13794-807. [PMID: 31589826 DOI: 10.1096/fj.201902003R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jaureguiberry MS, Venturino A. Nutritional and environmental contributions to Autism Spectrum Disorders: Focus on nutrigenomics as complementary therapy. Int J Vitam Nutr Res 2020;:1-19. [PMID: 32065556 DOI: 10.1024/0300-9831/a000630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kuda O, Rossmeisl M, Kopecky J. Omega-3 fatty acids and adipose tissue biology. Mol Aspects Med 2018;64:147-60. [PMID: 29329795 DOI: 10.1016/j.mam.2018.01.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
14 Sharma M, Schlegel MP, Afonso MS, Brown EJ, Rahman K, Weinstock A, Sansbury BE, Corr EM, van Solingen C, Koelwyn GJ, Shanley LC, Beckett L, Peled D, Lafaille JJ, Spite M, Loke P, Fisher EA, Moore KJ. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression. Circ Res 2020;127:335-53. [PMID: 32336197 DOI: 10.1161/CIRCRESAHA.119.316461] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
15 Pistorius K, Souza PR, De Matteis R, Austin-Williams S, Primdahl KG, Vik A, Mazzacuva F, Colas RA, Marques RM, Hansen TV, Dalli J. PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function. Cell Chem Biol 2018;25:749-760.e9. [PMID: 29805036 DOI: 10.1016/j.chembiol.2018.04.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
16 Shang P, Zhang Y, Ma D, Hao Y, Wang X, Xin M, Zhang Y, Zhu M, Feng J. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases. Expert Opin Ther Targets 2019;23:967-86. [PMID: 31711309 DOI: 10.1080/14728222.2019.1691525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Vaidya HB, Gangadaran S, Cheema SK. A high fat-high sucrose diet enriched in blue mussels protects against systemic inflammation, metabolic dysregulation and weight gain in C57BL/6 mice. Food Res Int 2017;100:78-85. [PMID: 28888461 DOI: 10.1016/j.foodres.2017.08.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Libreros S. Resolution of inflammation: Role of B cells. J Leukoc Biol 2019;106:235-9. [PMID: 31344281 DOI: 10.1002/JLB.3CE0119-015RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Sønderskov J, Tungen JE, Palmas F, Dalli J, Serhan CN, Stenstrøm Y, Hansen TV. Stereoselective synthesis of MaR2n-3 DPA. Tetrahedron Lett 2020;61:151510. [PMID: 33273748 DOI: 10.1016/j.tetlet.2019.151510] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. International Immunology 2019;31:559-67. [DOI: 10.1093/intimm/dxz001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
21 Chiang N, Barnaeva E, Hu X, Marugan J, Southall N, Ferrer M, Serhan CN. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions. Cell Chem Biol 2019;26:244-254.e4. [PMID: 30554914 DOI: 10.1016/j.chembiol.2018.10.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
22 Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
23 Wang G, Wang J, Xin C, Xiao J, Liang J, Wu X. Inflammatory response in epilepsy is mediated by glial cell gap junction pathway (Review). Mol Med Rep 2021;24:493. [PMID: 33955516 DOI: 10.3892/mmr.2021.12132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kooij G, Troletti CD, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, Gasperini C, Battistini L, de Vries HE, Serhan CN, Chiurchiù V. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. Haematologica 2020;105:2056-70. [PMID: 31780628 DOI: 10.3324/haematol.2019.219519] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
25 Kim AS, Conte MS. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Advanced Drug Delivery Reviews 2020;159:170-9. [DOI: 10.1016/j.addr.2020.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
27 Shati AA, El-Kott AF. Resolvin D1 protects against cadmium chloride-induced memory loss and hippocampal damage in rats: A comparison with docosahexaenoic acid. Hum Exp Toxicol 2021;40:S215-32. [PMID: 34405727 DOI: 10.1177/09603271211038739] [Reference Citation Analysis]
28 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
29 Livshits G, Kalinkovich A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Research Reviews 2019;56:100980. [DOI: 10.1016/j.arr.2019.100980] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
30 Yin P, Wang S, Wei Y, Wang X, Zhang J, Yin X, Feng J, Zhu M. Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-β42 in Neuron-Microglia Co-Culture Models. JAD 2020;73:503-15. [DOI: 10.3233/jad-190682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Dakin SG, Colas RA, Wheway K, Watkins B, Appleton L, Rees J, Gwilym S, Little C, Dalli J, Carr AJ. Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears. Am J Pathol 2019;189:2258-68. [PMID: 31437425 DOI: 10.1016/j.ajpath.2019.07.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
32 Philippe R, Urbach V. Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis. Int J Mol Sci 2018;19:E2865. [PMID: 30241412 DOI: 10.3390/ijms19102865] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
33 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
34 Aubeux D, Peters OA, Hosseinpour S, Tessier S, Geoffroy V, Pérez F, Gaudin A. Specialized pro-resolving lipid mediators in endodontics: a narrative review. BMC Oral Health 2021;21:276. [PMID: 34030680 DOI: 10.1186/s12903-021-01619-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Tiberi M, Chiurchiù V. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair. Front Cell Neurosci 2021;15:673549. [PMID: 33981203 DOI: 10.3389/fncel.2021.673549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, McEvoy N, McElvaney OJ, McElvaney O, Alalqam R, McElvaney NG, Curley GF, Dalli J. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One 2021;16:e0256226. [PMID: 34437568 DOI: 10.1371/journal.pone.0256226] [Reference Citation Analysis]
38 Han YH, Shin KO, Kim JY, Khadka DB, Kim HJ, Lee YM, Cho WJ, Cha JY, Lee BJ, Lee MO. A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. J Clin Invest 2019;129:1684-98. [PMID: 30855276 DOI: 10.1172/JCI124219] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
39 Han YH, Lee K, Saha A, Han J, Choi H, Noh M, Lee YH, Lee MO. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. Biomol Ther (Seoul) 2021;29:455-64. [PMID: 34162770 DOI: 10.4062/biomolther.2021.094] [Reference Citation Analysis]
40 Zaninelli TH, Fattori V, Verri WA Jr. Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators' Contribution to Arthritis Physiopathology and Future Perspectives. Front Physiol 2021;12:729134. [PMID: 34539449 DOI: 10.3389/fphys.2021.729134] [Reference Citation Analysis]
41 Coppey L, Davidson E, Shevalye H, Torres ME, Yorek MA. Effect of dietary oils on peripheral neuropathy-related endpoints in dietary obese rats. Diabetes Metab Syndr Obes 2018;11:117-27. [PMID: 29674850 DOI: 10.2147/DMSO.S159071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
42 Hellmann J, Sansbury BE, Wong B, Li X, Singh M, Nuutila K, Chiang N, Eriksson E, Serhan CN, Spite M. Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair. J Invest Dermatol 2018;138:2051-60. [PMID: 29559341 DOI: 10.1016/j.jid.2018.03.1498] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
43 Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, Ly L, Pistorius K, Kocher HM, Ricketts W, Thomas G, Perretti M, Alusi G, Pfeffer P, Dalli J. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Circ Res 2021;129:e54-71. [PMID: 34238021 DOI: 10.1161/CIRCRESAHA.121.319142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Parashar K, Schulte F, Hardt M, Baker OJ. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model. FASEB J 2020;34:7733-44. [PMID: 32277856 DOI: 10.1096/fj.201902196R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
45 Archambault AS, Turcotte C, Martin C, Provost V, Larose MC, Laprise C, Chakir J, Bissonnette É, Laviolette M, Bossé Y, Flamand N. Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils. PLoS One 2018;13:e0202424. [PMID: 30118527 DOI: 10.1371/journal.pone.0202424] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
46 Rosenthal MD, Bala T, Wang Z, Loftus T, Moore F. Chronic Critical Illness Patients Fail to Respond to Current Evidence-Based Intensive Care Nutrition Secondarily to Persistent Inflammation, Immunosuppression, and Catabolic Syndrome. JPEN J Parenter Enteral Nutr 2020;44:1237-49. [PMID: 32026502 DOI: 10.1002/jpen.1794] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
47 Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Front Immunol 2021;12:660865. [PMID: 34177900 DOI: 10.3389/fimmu.2021.660865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Dos Santos HT, Nam K, Maslow F, Trump B, Baker OJ. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome. Ann Diagn Pathol 2021;56:151865. [PMID: 34847389 DOI: 10.1016/j.anndiagpath.2021.151865] [Reference Citation Analysis]
49 Jung TW, Kyung EJ, Kim H, Shin YK, Lee SH, Park ES, Hacımüftüoğlu A, Abd El-aty AM, Jeong JH. Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression. J Pharmacol Exp Ther 2018;365:485-93. [DOI: 10.1124/jpet.117.246686] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
50 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
51 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
52 Conte MS, Desai TA, Wu B, Schaller M, Werlin E. Pro-resolving lipid mediators in vascular disease. J Clin Invest 2018;128:3727-35. [PMID: 30168805 DOI: 10.1172/JCI97947] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
53 Bogie JF, Haidar M, Kooij G, Hendriks JJ. Fatty acid metabolism in the progression and resolution of CNS disorders. Advanced Drug Delivery Reviews 2020;159:198-213. [DOI: 10.1016/j.addr.2020.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
54 Wolinski P, Ksiazek-winiarek D, Glabinski A. Cytokines and Neurodegeneration in Epileptogenesis. Brain Sciences 2022;12:380. [DOI: 10.3390/brainsci12030380] [Reference Citation Analysis]
55 Serhan CN, de la Rosa X, Jouvene C. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. J Intern Med 2019;286:240-58. [PMID: 30565762 DOI: 10.1111/joim.12871] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
56 Lee H, Tominaga M, Yasukawa K, Ohba M, Takahashi N, Honda K, Okuno T, Takamori K, Yokomizo T. Dietary supplementation of omega-3 fatty acid eicosapentaenoic acid does not ameliorate pruritus in murine models of atopic dermatitis and psoriasis. Journal of Dermatological Science 2019;95:130-3. [DOI: 10.1016/j.jdermsci.2019.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Markworth JF, Brown LA, Lim E, Floyd C, Larouche J, Castor-Macias JA, Sugg KB, Sarver DC, Macpherson PC, Davis C, Aguilar CA, Maddipati KR, Brooks SV. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells. JCI Insight 2020;5:137713. [PMID: 32750044 DOI: 10.1172/jci.insight.137713] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
58 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Reference Citation Analysis]
59 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
60 Markworth JF, Sugg KB, Sarver DC, Maddipati KR, Brooks SV. Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse. FASEB J 2021;35:e21655. [PMID: 34042218 DOI: 10.1096/fj.202100078R] [Reference Citation Analysis]
61 Ali M, Kucko N, Jansen JA, Yang F, Walboomers XF. The effect of lipoxin A4 on E. coli LPS-induced osteoclastogenesis. Clin Oral Investig 2021;25:957-69. [PMID: 32506323 DOI: 10.1007/s00784-020-03385-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ. Key roles for lipid mediators in the adaptive immune response. J Clin Invest 2018;128:2724-31. [PMID: 30108196 DOI: 10.1172/JCI97951] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
63 Calder PC. Nutrition, immunity and COVID-19.BMJ Nutr Prev Health. 2020;3:74-92. [PMID: 33230497 DOI: 10.1136/bmjnph-2020-000085] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 50.0] [Reference Citation Analysis]
64 Leuti A, Fava M, Pellegrini N, Maccarrone M. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain. Front Pharmacol 2021;12:717993. [PMID: 34456731 DOI: 10.3389/fphar.2021.717993] [Reference Citation Analysis]
65 Yellepeddi VK, Baker OJ. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome. Clin Exp Dent Res 2020;6:225-35. [PMID: 32250566 DOI: 10.1002/cre2.260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation 2018;15:144. [PMID: 29764485 DOI: 10.1186/s12974-018-1192-7] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 37.3] [Reference Citation Analysis]
67 Perucci LO, de Castro Pinto KM, da Silva SPG, Lage EM, Teixeira PG, Barbosa AS, Alpoim PN, de Sousa LP, Talvani A, Dusse LMS. Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia. Clin Biochem 2021:S0009-9120(21)00230-7. [PMID: 34492288 DOI: 10.1016/j.clinbiochem.2021.09.002] [Reference Citation Analysis]
68 Yang Z, Wang J, He B, Zhang X, Li X, Kuang E. RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination. Elife 2021;10:e68958. [PMID: 34313226 DOI: 10.7554/eLife.68958] [Reference Citation Analysis]
69 Spite M. Resolving inflammation in nonalcoholic steatohepatitis. J Clin Invest 2019;129:1524-6. [PMID: 30855277 DOI: 10.1172/JCI127583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
70 Coppey L, Davidson E, Shevalye H, Obrosov A, Yorek M. Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model. J Diabetes Res 2019;2019:5020465. [PMID: 31485451 DOI: 10.1155/2019/5020465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
71 Ferguson B, Bokka NR, Maddipati KR, Ayilavarapu S, Weltman R, Zhu L, Chen W, Zheng WJ, Angelov N, Van Dyke TE, Lee CT. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation. Front Immunol 2020;11:1307. [PMID: 32670289 DOI: 10.3389/fimmu.2020.01307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
72 Luo Y, Kiriya M, Tanigawa K, Kawashima A, Nakamura Y, Ishii N, Suzuki K. Host-Related Laboratory Parameters for Leprosy Reactions. Front Med (Lausanne) 2021;8:694376. [PMID: 34746168 DOI: 10.3389/fmed.2021.694376] [Reference Citation Analysis]
73 Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 2018;98:1335-70. [PMID: 29717929 DOI: 10.1152/physrev.00026.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
74 Tungen JE, Gerstmann L, Vik A, De Matteis R, Colas RA, Dalli J, Chiang N, Serhan CN, Kalesse M, Hansen TV. Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA. Chemistry 2019;25:1476-80. [PMID: 30511787 DOI: 10.1002/chem.201806029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
75 Liang N, Emami S, Patten KT, Valenzuela AE, Wallis CD, Wexler AS, Bein KJ, Lein PJ, Taha AY. Chronic exposure to traffic-related air pollution reduces lipid mediators of linoleic acid and soluble epoxide hydrolase in serum of female rats. Environ Toxicol Pharmacol 2022;:103875. [PMID: 35550873 DOI: 10.1016/j.etap.2022.103875] [Reference Citation Analysis]
76 Radbakhsh S, Katsiki N, Santos RD, Mikhailidis DP, Mantzoros CS, Sahebkar A. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation. Metabolism 2022;:155211. [PMID: 35533891 DOI: 10.1016/j.metabol.2022.155211] [Reference Citation Analysis]
77 Wierenga KA, Wee J, Gilley KN, Rajasinghe LD, Bates MA, Gavrilin MA, Holian A, Pestka JJ. Docosahexaenoic Acid Suppresses Silica-Induced Inflammasome Activation and IL-1 Cytokine Release by Interfering With Priming Signal. Front Immunol 2019;10:2130. [PMID: 31616405 DOI: 10.3389/fimmu.2019.02130] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
78 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
79 Sezin T, Ferreirós N, Jennrich M, Ochirbold K, Seutter M, Attah C, Mousavi S, Zillikens D, Geisslinger G, Sadik CD. 12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation. Journal of Autoimmunity 2020;115:102528. [DOI: 10.1016/j.jaut.2020.102528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Wagner KM, McReynolds CB, Schmidt WK, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther 2017;180:62-76. [PMID: 28642117 DOI: 10.1016/j.pharmthera.2017.06.006] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 21.8] [Reference Citation Analysis]
81 Dalli J, Pistorius K, Walker ME. Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation. In: Honn KV, Zeldin DC, editors. The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases. Cham: Springer International Publishing; 2019. pp. 65-75. [DOI: 10.1007/978-3-030-21735-8_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
82 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
83 Fattori V, Pinho-Ribeiro FA, Staurengo-Ferrari L, Borghi SM, Rossaneis AC, Casagrande R, Verri WA Jr. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect. Br J Pharmacol 2019;176:1728-44. [PMID: 30830967 DOI: 10.1111/bph.14647] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
84 Chiurchiù V, Leuti A, Maccarrone M. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front Immunol 2018;9:38. [PMID: 29434586 DOI: 10.3389/fimmu.2018.00038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 35.0] [Reference Citation Analysis]
85 Briottet M, Shum M, Urbach V. The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. Front Pharmacol 2020;11:1290. [PMID: 32982730 DOI: 10.3389/fphar.2020.01290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Mizuno H, Kihara Y. Druggable Lipid GPCRs: Past, Present, and Prospects. Adv Exp Med Biol 2020;1274:223-58. [PMID: 32894513 DOI: 10.1007/978-3-030-50621-6_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
87 Yang A, Wu Y, Yu G, Wang H. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development. Respir Res 2021;22:204. [PMID: 34261470 DOI: 10.1186/s12931-021-01792-y] [Reference Citation Analysis]
88 Zhang L, Jia M, Sun T. The roles of special proresolving mediators in pain relief. Reviews in the Neurosciences 2018;29:645-60. [DOI: 10.1515/revneuro-2017-0074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
89 de Macedo CS, de Carvalho FM, Amaral JJ, de Mendonça Ochs S, Assis EF, Sarno EN, Bozza PT, Pessolani MCV. Leprosy and its reactional episodes: Serum levels and possible roles of omega-3 and omega-6-derived lipid mediators. Cytokine 2018;112:87-94. [DOI: 10.1016/j.cyto.2018.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
90 Fernandez RF, Pereyra AS, Diaz V, Wilson ES, Litwa KA, Martínez-Gardeazabal J, Jackson SN, Brenna JT, Hermann BP, Eells JB, Ellis JM. Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging. JCI Insight 2021;6:144351. [PMID: 34100386 DOI: 10.1172/jci.insight.144351] [Reference Citation Analysis]
91 Holopainen M, Colas RA, Valkonen S, Tigistu-sahle F, Hyvärinen K, Mazzacuva F, Lehenkari P, Käkelä R, Dalli J, Kerkelä E, Laitinen S. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019;1864:1350-62. [DOI: 10.1016/j.bbalip.2019.06.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
92 Silberberg E, Filep JG, Ariel A. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Front Immunol 2022;13:863449. [DOI: 10.3389/fimmu.2022.863449] [Reference Citation Analysis]
93 Dalli J, Serhan CN. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front Immunol 2017;8:1400. [PMID: 29163481 DOI: 10.3389/fimmu.2017.01400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
94 Simard M, Rioux G, Morin S, Martin C, Guérin SL, Flamand N, Julien P, Fradette J, Pouliot R. Investigation of Omega-3 Polyunsaturated Fatty Acid Biological Activity in a Tissue-Engineered Skin Model Involving Psoriatic Cells. J Invest Dermatol 2021:S0022-202X(21)01126-X. [PMID: 33857488 DOI: 10.1016/j.jid.2021.02.755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 de la Rosa X, Norris PC, Chiang N, Rodriguez AR, Spur BW, Serhan CN. Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration. Am J Pathol 2018;188:950-66. [PMID: 29571326 DOI: 10.1016/j.ajpath.2018.01.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
96 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Fattori V, Ferraz CR, Rasquel-Oliveira FS, Verri WA Jr. Neuroimmune communication in infection and pain: Friends or foes? Immunol Lett 2021;229:32-43. [PMID: 33248166 DOI: 10.1016/j.imlet.2020.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Teixeira-Santos L, Albino-Teixeira A, Pinho D. Neuroinflammation, oxidative stress and their interplay in neuropathic pain: Focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies. Pharmacol Res 2020;162:105280. [PMID: 33161139 DOI: 10.1016/j.phrs.2020.105280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 2020;64:443-62. [PMID: 32885825 DOI: 10.1042/EBC20200018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
100 Kalinkovich A, Pouyrovsky M, Nasyrova R, Livshits G. Biased activation of inflammation pro-resolving receptors as an evolving supportive strategy in schizophrenia treatment. Schizophr Res 2021;228:295-7. [PMID: 33497903 DOI: 10.1016/j.schres.2021.01.003] [Reference Citation Analysis]
101 Teopompi E, Risé P, Pisi R, Buccellati C, Aiello M, Pisi G, Tripodi C, Fainardi V, Clini E, Chetta A, Rovati GE, Sala A. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation. Front Pharmacol 2019;10:938. [PMID: 31507425 DOI: 10.3389/fphar.2019.00938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
102 Martinez RM, Fattori V, Saito P, Pinto IC, Rodrigues CCA, Melo CPB, Bussmann AJC, Staurengo-Ferrari L, Bezerra JR, Vignoli JA, Baracat MM, Georgetti SR, Verri WA Jr, Casagrande R. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. Molecules 2020;25:E2953. [PMID: 32604968 DOI: 10.3390/molecules25122953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Reis MB, Pereira PAT, Caetano GF, Leite MN, Galvão AF, Paula-Silva FWG, Frade MAC, Faccioli LH. Lipoxin A4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers. PLoS One 2017;12:e0182381. [PMID: 28753648 DOI: 10.1371/journal.pone.0182381] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
104 Garić D, Dumut DC, Shah J, De Sanctis JB, Radzioch D. The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. Cell Mol Life Sci 2020;77:4255-67. [PMID: 32394023 DOI: 10.1007/s00018-020-03530-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Saban DR, Hodges RR, Mathew R, Reyes NJ, Yu C, Kaye R, Swift W, Botten N, Serhan CN, Dartt DA. Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model. Mucosal Immunol 2019;12:145-53. [PMID: 30279513 DOI: 10.1038/s41385-018-0089-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
106 Nirujogi TS, Kotha SR, Chung S, Reader BF, Yenigalla A, Zhang L, Shapiro JP, Wisler J, Christman JW, Maddipati K, Parinandi NL, Karpurapu M. Lipidomic Profiling of Bronchoalveolar Lavage Fluid Extracellular Vesicles Indicates Their Involvement in Lipopolysaccharide-Induced Acute Lung Injury. J Innate Immun. [DOI: 10.1159/000522338] [Reference Citation Analysis]
107 David S, López-Vales R. Bioactive Lipid Mediators in the Initiation and Resolution of Inflammation after Spinal Cord Injury. Neuroscience 2021;466:273-97. [PMID: 33951502 DOI: 10.1016/j.neuroscience.2021.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Perez-Hernandez J, Chiurchiù V, Perruche S, You S. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators. Front Immunol 2021;12:768133. [PMID: 34868025 DOI: 10.3389/fimmu.2021.768133] [Reference Citation Analysis]
109 Mena HA, Spite M. Proresolving receptor tames inflammation in atherosclerosis. J Clin Invest 2021;131:e155240. [PMID: 34907914 DOI: 10.1172/JCI155240] [Reference Citation Analysis]
110 Fredman G, MacNamara KC. Atherosclerosis is a Major Human Killer and Non-resolving Inflammation is a Prime Suspect. Cardiovasc Res 2021:cvab309. [PMID: 34609505 DOI: 10.1093/cvr/cvab309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Pellicano C, Romaggioli L, Miglionico M, Colalillo A, Ramaccini C, Gigante A, Muscaritoli M, Rosato E. Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients. Microvasc Res 2022;:104366. [PMID: 35346718 DOI: 10.1016/j.mvr.2022.104366] [Reference Citation Analysis]
112 Wei C, Guo S, Liu W, Jin F, Wei B, Fan H, Su H, Liu J, Zhang N, Fang D, Li G, Shu S, Li X, He X, Zhang X, Duan C. Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome. Front Pharmacol 2020;11:610734. [PMID: 33732145 DOI: 10.3389/fphar.2020.610734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
113 Reeves AR, Sansbury BE, Pan M, Han X, Spite M, Greenberg AS. Myeloid-Specific Deficiency of Long-Chain Acyl CoA Synthetase 4 Reduces Inflammation by Remodeling Phospholipids and Reducing Production of Arachidonic Acid-Derived Proinflammatory Lipid Mediators. J Immunol 2021;207:2744-53. [PMID: 34725110 DOI: 10.4049/jimmunol.2100393] [Reference Citation Analysis]
114 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
115 Bremner JD, Moazzami K, Wittbrodt MT, Nye JA, Lima BB, Gillespie CF, Rapaport MH, Pearce BD, Shah AJ, Vaccarino V. Diet, Stress and Mental Health. Nutrients 2020;12:E2428. [PMID: 32823562 DOI: 10.3390/nu12082428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
116 Son SE, Park SJ, Koh JM, Im DS. Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice. Acta Pharmacol Sin 2020;41:1337-47. [PMID: 32555509 DOI: 10.1038/s41401-020-0435-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Schaller MS, Chen M, Colas RA, Sorrentino TA, Lazar AA, Grenon SM, Dalli J, Conte MS. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease. J Am Heart Assoc 2020;9:e016113. [PMID: 32696697 DOI: 10.1161/JAHA.120.016113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
118 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
119 Rogero MM, Calder PC. Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. Nutrients. 2018;10. [PMID: 29601492 DOI: 10.3390/nu10040432] [Cited by in Crossref: 198] [Cited by in F6Publishing: 181] [Article Influence: 49.5] [Reference Citation Analysis]
120 Bakker N, van den Helder RS, Stoutjesdijk E, van Pelt J, Houdijk APJ. Effects of perioperative intravenous ω-3 fatty acids in colon cancer patients: a randomized, double-blind, placebo-controlled clinical trial. The American Journal of Clinical Nutrition 2020;111:385-95. [DOI: 10.1093/ajcn/nqz281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
121 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Reference Citation Analysis]
122 Rosenthal MD, Patel J, Staton K, Martindale RG, Moore FA, Upchurch GR Jr. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil? Curr Gastroenterol Rep 2018;20:40. [PMID: 30078085 DOI: 10.1007/s11894-018-0647-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
123 Vanzant E, Loftus T, Kamel A, Carmichael E, Rosenthal MD. Nutritional impact of omega 3 fatty acids and metabolites in acute and chronic critical illness. Curr Opin Clin Nutr Metab Care 2022;25:75-80. [PMID: 35115447 DOI: 10.1097/MCO.0000000000000818] [Reference Citation Analysis]
124 Vidal-Peracho C, Tricás-Moreno JM, Lucha-López AC, Lucha-López MO, Camuñas-Pescador AC, Caverni-Muñoz A, Fanlo-Mazas P. Adherence to Mediterranean Diet Pattern among Spanish Adults Attending a Medical Centre: Nondiabetic Subjects and Type 1 and 2 Diabetic Patients. J Diabetes Res 2017;2017:5957821. [PMID: 29527536 DOI: 10.1155/2017/5957821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
125 Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Pace S, Werz O. Impact of Androgens on Inflammation-Related Lipid Mediator Biosynthesis in Innate Immune Cells. Front Immunol 2020;11:1356. [PMID: 32714332 DOI: 10.3389/fimmu.2020.01356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Romano M, Patruno S, Pomilio A, Recchiuti A. Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem Cells Transl Med 2019;8:992-8. [PMID: 31187940 DOI: 10.1002/sctm.19-0078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
128 Chuong P, Wysoczynski M, Hellmann J. Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise? Front Cardiovasc Med 2019;6:70. [PMID: 31192231 DOI: 10.3389/fcvm.2019.00070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
129 Larrieu T, Layé S. Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety. Front Physiol 2018;9:1047. [PMID: 30127751 DOI: 10.3389/fphys.2018.01047] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
130 Lotfi R, Rezaiemanesh A, Mortazavi SH, Karaji AG, Salari F. Immunoresolvents in asthma and allergic diseases: Review and update. J Cell Physiol 2019;234:8579-96. [PMID: 30488527 DOI: 10.1002/jcp.27836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
131 Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharmacol Ther 2021;227:107893. [PMID: 33992683 DOI: 10.1016/j.pharmthera.2021.107893] [Reference Citation Analysis]
132 Bolotov DD, Novikov AA, Bolevich S, Novikova NA, Yakovchenko AV. Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation. Serbian Journal of Experimental and Clinical Research 2020;21:3-10. [DOI: 10.2478/sjecr-2020-0013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Sekheri M, Othman A, Filep JG. β2 Integrin Regulation of Neutrophil Functional Plasticity and Fate in the Resolution of Inflammation. Front Immunol 2021;12:660760. [PMID: 33859651 DOI: 10.3389/fimmu.2021.660760] [Reference Citation Analysis]
134 Lee CH. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res 2021;44:84-98. [PMID: 33398691 DOI: 10.1007/s12272-020-01299-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
135 Joffre C, Rey C, Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front Pharmacol 2019;10:1022. [PMID: 31607902 DOI: 10.3389/fphar.2019.01022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
136 Yan YY, Li CY, Zhou L, Ao LY, Fang WR, Li YM. Research progress of mechanisms and drug therapy for neuropathic pain. Life Sci 2017;190:68-77. [PMID: 28964813 DOI: 10.1016/j.lfs.2017.09.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
137 Bisicchia E, Sasso V, Molinari M, Viscomi MT. Plasticity of microglia in remote regions after focal brain injury. Semin Cell Dev Biol 2019;94:104-11. [PMID: 30703556 DOI: 10.1016/j.semcdb.2019.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
138 Yu N, Van Dyke TE. Periodontitis: a host mediated disruption of microbial homeostasis. Curr Oral Health Rep 2020;7:3-11. [PMID: 34113536 DOI: 10.1007/s40496-020-00256-4] [Reference Citation Analysis]
139 Paloque L, Perez-Berezo T, Abot A, Dalloux-Chioccioli J, Bourgeade-Delmas S, Le Faouder P, Pujo J, Teste MA, François JM, Schebb NH, Mainka M, Rolland C, Blanpied C, Dietrich G, Bertrand-Michel J, Deraison C, Valentin A, Cenac N. Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interaction. J Lipid Res 2019;60:636-47. [PMID: 30626624 DOI: 10.1194/jlr.M091736] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
140 Fernandez RF, Ellis JM. Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity. Prostaglandins Leukot Essent Fatty Acids 2020;161:102175. [PMID: 33031993 DOI: 10.1016/j.plefa.2020.102175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
142 Morse NL, Reid AJ, St-Onge M. An open-label clinical trial assessing the efficacy and safety of Bend Skincare Anti-Aging Formula on minimal erythema dose in skin. Photodermatol Photoimmunol Photomed 2018;34:152-61. [PMID: 28884844 DOI: 10.1111/phpp.12350] [Reference Citation Analysis]
143 López-Vales R, David S. Bioactive Lipids in Inflammation After Central Nervous System Injury. Adv Exp Med Biol 2019;1127:181-94. [PMID: 31140179 DOI: 10.1007/978-3-030-11488-6_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 Dyall SC, Balas L, Bazan NG, Brenna JT, Chiang N, da Costa Souza F, Dalli J, Durand T, Galano J, Lein PJ, Serhan CN, Taha AY. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions. Progress in Lipid Research 2022. [DOI: 10.1016/j.plipres.2022.101165] [Reference Citation Analysis]
145 Falsetta ML, Wood RW, Linder MA, Bonham AD, Honn KV, Maddipati KR, Phipps RP, Haidaris CG, Foster DC. Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia. J Pain 2021:S1526-5900(21)00185-1. [PMID: 33813057 DOI: 10.1016/j.jpain.2021.03.144] [Reference Citation Analysis]
146 Kalkman HO, Hersberger M, Walitza S, Berger GE. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. Int J Mol Sci 2021;22:4393. [PMID: 33922396 DOI: 10.3390/ijms22094393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Gao Y, Su J, Zhang Y, Chan A, Sin JH, Wu D, Min K, Gronert K. Dietary DHA amplifies LXA4 circuits in tissues and lymph node PMN and is protective in immune-driven dry eye disease. Mucosal Immunol 2018;11:1674-83. [PMID: 30104626 DOI: 10.1038/s41385-018-0070-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
148 Calder PC. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake. Biochimie 2020;178:105-23. [PMID: 32860894 DOI: 10.1016/j.biochi.2020.08.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
149 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
150 Sánchez-Fernández A, Zandee S, Mastrogiovanni M, Charabati M, Rubbo H, Prat A, López-Vales R. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. J Neuroinflammation 2022;19:27. [PMID: 35109863 DOI: 10.1186/s12974-022-02386-1] [Reference Citation Analysis]
151 Leuti A, Maccarrone M, Chiurchiù V. Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress. Oxid Med Cell Longev 2019;2019:8107265. [PMID: 31316721 DOI: 10.1155/2019/8107265] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
152 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Reference Citation Analysis]
153 Dean S, Wang CS, Nam K, Maruyama CL, Trump BG, Baker OJ. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model. Rheumatology (Oxford) 2019;58:1285-92. [PMID: 30877775 DOI: 10.1093/rheumatology/kez072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
154 Flitter BA, Fang X, Matthay MA, Gronert K. The potential of lipid mediator networks as ocular surface therapeutics and biomarkers. Ocul Surf 2021;19:104-14. [PMID: 32360792 DOI: 10.1016/j.jtos.2020.04.008] [Reference Citation Analysis]